A detailed history of Swiss National Bank transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Swiss National Bank holds 321,600 shares of REGN stock, worth $230 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
321,600
Previous 319,600 0.63%
Holding current value
$230 Million
Previous $336 Million 0.65%
% of portfolio
0.22%
Previous 0.24%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$1024.09 - $1201.76 $2.05 Million - $2.4 Million
2,000 Added 0.63%
321,600 $338 Million
Q2 2024

Aug 08, 2024

SELL
$883.2 - $1071.19 $1.06 Million - $1.29 Million
-1,200 Reduced 0.37%
319,600 $336 Million
Q1 2024

May 07, 2024

SELL
$902.69 - $993.35 $11.7 Million - $12.9 Million
-13,000 Reduced 3.89%
320,800 $309 Million
Q4 2023

Feb 06, 2024

SELL
$775.18 - $881.7 $10.3 Million - $11.7 Million
-13,300 Reduced 3.83%
333,800 $293 Million
Q3 2023

Nov 08, 2023

SELL
$692.45 - $844.37 $28.5 Million - $34.8 Million
-41,200 Reduced 10.61%
347,100 $286 Million
Q2 2023

Aug 09, 2023

SELL
$700.03 - $830.35 $25.7 Million - $30.5 Million
-36,700 Reduced 8.64%
388,300 $279 Million
Q1 2023

May 10, 2023

SELL
$680.49 - $826.97 $7.21 Million - $8.77 Million
-10,600 Reduced 2.43%
425,000 $349 Million
Q4 2022

Feb 08, 2023

SELL
$705.89 - $766.39 $23 Million - $25 Million
-32,572 Reduced 6.96%
435,600 $314 Million
Q3 2022

Nov 09, 2022

BUY
$573.97 - $724.32 $3.04 Million - $3.84 Million
5,300 Added 1.15%
468,172 $323 Million
Q2 2022

Aug 09, 2022

BUY
$548.35 - $738.84 $2.74 Million - $3.69 Million
5,000 Added 1.09%
462,872 $274 Million
Q1 2022

May 09, 2022

BUY
$595.12 - $698.43 $34.8 Million - $40.8 Million
58,400 Added 14.62%
457,872 $320 Million
Q4 2021

Feb 08, 2022

SELL
$543.48 - $670.97 $7.88 Million - $9.73 Million
-14,500 Reduced 3.5%
399,472 $252 Million
Q3 2021

Nov 08, 2021

SELL
$574.03 - $680.96 $8.84 Million - $10.5 Million
-15,400 Reduced 3.59%
413,972 $251 Million
Q2 2021

Aug 06, 2021

SELL
$472.8 - $558.54 $83.9 Million - $99.1 Million
-177,450 Reduced 29.24%
429,372 $240 Million
Q1 2021

May 07, 2021

BUY
$446.73 - $548.2 $4.78 Million - $5.87 Million
10,700 Added 1.79%
606,822 $287 Million
Q4 2020

Feb 05, 2021

BUY
$478.3 - $607.98 $12.4 Million - $15.8 Million
26,000 Added 4.56%
596,122 $288 Million
Q3 2020

Nov 09, 2020

BUY
$544.75 - $658.21 $49.3 Million - $59.6 Million
90,500 Added 18.87%
570,122 $319 Million
Q2 2020

Aug 05, 2020

BUY
$493.32 - $643.92 $81.6 Million - $107 Million
165,400 Added 52.64%
479,622 $299 Million
Q1 2020

May 08, 2020

BUY
$336.18 - $494.43 $19.8 Million - $29.1 Million
58,800 Added 23.02%
314,222 $153 Million
Q4 2019

Feb 06, 2020

SELL
$274.13 - $376.51 $3.13 Million - $4.29 Million
-11,400 Reduced 4.27%
255,422 $95.9 Million
Q3 2019

Nov 12, 2019

BUY
$273.46 - $318.39 $1.21 Million - $1.41 Million
4,422 Added 1.69%
266,822 $74 Million
Q2 2019

Aug 02, 2019

SELL
$299.6 - $414.82 $1.14 Million - $1.58 Million
-3,800 Reduced 1.43%
262,400 $82.1 Million
Q1 2019

May 10, 2019

BUY
$372.08 - $439.57 $2.75 Million - $3.25 Million
7,400 Added 2.86%
266,200 $109 Million
Q4 2018

Feb 13, 2019

BUY
$335.82 - $403.04 $1.71 Million - $2.06 Million
5,100 Added 2.01%
258,800 $96.7 Million
Q3 2018

Nov 08, 2018

SELL
$351.14 - $408.51 $2.84 Million - $3.31 Million
-8,100 Reduced 3.09%
253,700 $103 Million
Q2 2018

Aug 09, 2018

BUY
$284.6 - $344.99 $2.25 Million - $2.73 Million
7,900 Added 3.11%
261,800 $90.3 Million
Q1 2018

May 04, 2018

SELL
$315.82 - $393.78 $11.1 Million - $13.8 Million
-35,000 Reduced 12.11%
253,900 $87.4 Million
Q4 2017

Feb 07, 2018

BUY
$358.63 - $469.95 $143,452 - $187,980
400 Added 0.14%
288,900 $109 Million
Q3 2017

Nov 03, 2017

BUY
$431.38 - $504.0 $124 Million - $145 Million
288,500
288,500 $129 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.